TrianglePUBLICATIONS · 24335103
Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2014 Feb 20
- First author
- Querfeld C
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Querfeld C
- type
- Author
- name
- Rosen ST
- type
- Author
- name
- Guitart J
- type
- Author
- name
- Duvic M
- type
- Author
- name
- Kim YH
- type
- Author
- name
- Dusza SW
- type
- Author
- name
- Kuzel TM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Querfeld C
- type
- Author
- name
- Rosen ST
- type
- Author
- name
- Guitart J
- type
- Author
- name
- Duvic M
- type
- Author
- name
- Kim YH
- type
- Author
- name
- Dusza SW
- type
- Author
- name
- Kuzel TM
- type
- Author
- bibliography ids
- nci-bib-b5c9b65ea598c2c07ba467e8
- book metadata
- content sha256
- a3bdcb4b975c73f11031f213db79351930c4b4b47f48fc021e1341471451d8a0
- document type
- citation
- dois
- 10.1182/blood-2013-09-525915
- electronic publication date
- display
- 2013 Dec 11
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:24335103
- immutable id
- pubmed:24335103@a3bdcb4b975c73f11031f213db79351930c4b4b47f48fc021e1341471451d8a0
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 8
- name
- Blood
- nlm unique id
- 7603509
- pages
- 1159-66
- volume
- 123
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 24335103
- provenance
- batch id
- af10498814d931b53231
- provider
- NCBI PubMed ESummary
- record sha256
- 96ad3e5e960cd9901a08418d985d06892fbd390d56cc3089c6d8c5ef6fba23f7
- response sha256
- 077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
- retrieved at
- 2026-09-09T23:47:00.193465+00:00
- publication date
- display
- 2014 Feb 20
- precision
- day
- year
- 2014
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome.
Preserved source evidence · Not medical advice